Healthcare
M&A Advisory
Pharmaceutical
M&A Advisory
Lazard
Full Credential Description
Savient Pharmaceuticals. United States. Announced Date 03/04/2009. Closed Date 08/04/2009. Deal value: $31m. Registered direct offering of common stock. Industry: Savient Pharmaceuticals was a biopharmaceutical company focused on developing and commercializing treatments for rare diseases.